Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   skeletal dysplasia
  

Disease ID 1039
Disease skeletal dysplasia
Definition
Abnormal development of cartilage and bone.
Synonym
congenital skeletal dysplasia
osteochondrodysplasia (disorder)
osteochondrodysplasia syndrome
osteochondrodysplasia syndrome (disorder)
osteochondrodysplasia, nos
osteochondrodysplasias
osteochondrodysplasias [disease/finding]
DOID
UMLS
C0029422
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:23)
C0001080  |  achondroplasia  |  3
C0220659  |  acrodysostosis  |  1
C0010964  |  dandy-walker malformation  |  1
C0221355  |  macrocephaly  |  1
C0036439  |  scoliosis  |  1
C0000889  |  acanthosis nigricans  |  1
C0014544  |  epilepsy  |  1
C0022408  |  arthropathy  |  1
C0008925  |  cleft palate  |  1
C0031117  |  peripheral neuropathy  |  1
C0265294  |  metaphyseal dysplasia  |  1
C0344530  |  megalocornea  |  1
C0011847  |  diabetes  |  1
C0036440  |  idiopathic scoliosis  |  1
C0026707  |  morquio syndrome  |  1
C0010278  |  craniosynostosis  |  1
C0027092  |  myopia  |  1
C0007286  |  carpal tunnel syndrome  |  1
C0085113  |  neurofibromatosis  |  1
C0028754  |  obesity  |  1
C0026848  |  myopathy  |  1
C0221357  |  brachydactyly  |  1
C0009782  |  connective tissue disorder  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:15)
BCL2  |  596  |  CTD_human
KDR  |  3791  |  CTD_human
TRPV4  |  59341  |  CTD_human
FLNA  |  2316  |  CTD_human
VEGFA  |  7422  |  CTD_human
DLL3  |  10683  |  CTD_human
COL9A1  |  1297  |  CTD_human
COL11A1  |  1301  |  CTD_human
COL2A1  |  1280  |  CTD_human
SOST  |  50964  |  CTD_human
FLT1  |  2321  |  CTD_human
ADAMTSL2  |  9719  |  CTD_human
GLB1  |  2720  |  CTD_human
TRAPPC2  |  6399  |  CTD_human
HSPG2  |  3339  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:1)
1302  |  COL11A2  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1039
Disease skeletal dysplasia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:51)
HP:0004322  |  Stature below 3rd percentile  |  12
HP:0003508  |  Short stature, proportionate  |  3
HP:0003498  |  Disproportionate short stature  |  3
HP:0008462  |  Cervical instability  |  2
HP:0008873  |  Dwarfism, short-limbed  |  2
HP:0003510  |  Proportionate dwarfism  |  2
HP:0001510  |  Growth deficiency  |  1
HP:0005881  |  Spinal instability  |  1
HP:0000256  |  Macrocrania  |  1
HP:0002650  |  Scoliosis  |  1
HP:0001627  |  Congenital heart defects  |  1
HP:0001249  |  Mental retardation  |  1
HP:0002949  |  Fused cervical vertebrae  |  1
HP:0002486  |  Myotonia  |  1
HP:0011001  |  Increased bone mineral density  |  1
HP:0000568  |  Abnormally small globe of eye  |  1
HP:0011003  |  High myopia  |  1
HP:0008845  |  Mesomelic dwarfism  |  1
HP:0000098  |  Increased body height  |  1
HP:0000943  |  Dysostosis multiplex  |  1
HP:0005616  |  Early bone maturation  |  1
HP:0000956  |  Keratosis nigricans  |  1
HP:0002089  |  Hypoplastic lungs  |  1
HP:0005257  |  Small chest  |  1
HP:0000926  |  Flattened vertebral bodies  |  1
HP:0012245  |  Sex reversal  |  1
HP:0002282  |  Heterotopias  |  1
HP:0009826  |  limb shortening  |  1
HP:0000078  |  Genital abnormalities  |  1
HP:0001263  |  Developmental retardation  |  1
HP:0003040  |  Arthropathy  |  1
HP:0000175  |  Palatoschisis  |  1
HP:0100255  |  Metaphyseal dysplasia  |  1
HP:0000485  |  Enlarged cornea  |  1
HP:0000365  |  Hearing impairment  |  1
HP:0009830  |  Peripheral neuritis  |  1
HP:0010442  |  Polydactyly  |  1
HP:0000545  |  Near sightedness  |  1
HP:0001305  |  Dandy-Walker cyst  |  1
HP:0001363  |  Early fusion of cranial sutures  |  1
HP:0001067  |  Neurofibromas  |  1
HP:0100806  |  Sepsis  |  1
HP:0003026  |  shortened long tubular bones  |  1
HP:0003198  |  Myopathic changes  |  1
HP:0000924  |  Abnormality of the skeletal system  |  1
HP:0006487  |  Camptomelia  |  1
HP:0001156  |  Brachydactyly  |  1
HP:0001513  |  Obesity  |  1
HP:0100777  |  Exostoses  |  1
HP:0001511  |  Prenatal onset growth retardation  |  1
HP:0000164  |  Abnormality of the teeth  |  1
Disease ID 1039
Disease skeletal dysplasia
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:3)
C0013336  |  dwarfism  |  2
C0158981  |  neonatal diabetes  |  1
C0011847  |  diabetes  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:44)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs116571438NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109788483GA,T
rs121912632NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792407CT
rs121912633NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792396CT
rs121912634NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109798768TC
rs121912635NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109788462CA
rs121912636NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109798775TC,A
rs121912637NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109784378GC,A
rs121913105251199672261FGFR3umls:C0410528BeFreeFGFR3-related condition: a skeletal dysplasia with similarities to thanatophoric dysplasia and SADDAN due to Lys650Met.0.0070574892014FGFR341806163AC,T
rs121913105100530062261FGFR3umls:C0410528BeFreeA novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.0.0070574891999FGFR341806163AC,T
rs121913482128333942261FGFR3umls:C0410528BeFreeIn this communication, we report the identification of a mosaic R248C missense mutation in the IgII-III linker region of the gene encoding the fibroblast growth factor receptor-3 (FGFR3), in an individual who manifests a skeletal dysplasia and epidermal hyperplasia.0.0070574892003FGFR341801837CT
rs187864727NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109803054CA,T
rs267607147NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109784379GC,A
rs267607148NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109800639CT
rs267607149NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109784385CT
rs267607150NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792671TC
rs28931614114725792261FGFR3umls:C0410528BeFreeAchondroplasia is a skeletal dysplasia caused by substitution of arginine for glycine at codon 380 (G380R) mutation of the fibroblast growth factor receptor 3.0.0070574892001FGFR341804392GA,C
rs387906324NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109808308CT
rs387906902NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109793560GT
rs387906903NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109803113TC
rs387906904NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109803009GA
rs387906906NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109786827GA
rs387906907NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109800645TC
rs397514473NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109814531GA
rs397514474NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109814565CA
rs515726152NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109798742CA
rs515726153NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109796638TC
rs515726154NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109794406AGA-
rs515726155NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109793948-AGG
rs515726157NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792704TC
rs515726158NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792702AG
rs515726159NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792689AG
rs515726160NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792678CA
rs515726161NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792664GC
rs515726162NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792403GT
rs515726163NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792401AG
rs515726164NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792379CT
rs515726165NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109786716CT
rs515726166NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109784362GGTCTCATTCTTGCCCG-
rs515726167NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109803106CG
rs515726169NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109800754CG
rs515726171NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109798883TC
rs515726172NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109798774AG
rs77975504NA59341TRPV4umls:C0410528CLINVARNA0.122714419NATRPV412109792695CT
rs78311289180009032261FGFR3umls:C0029422BeFreeAcanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.0.0029099162007FGFR341806162AC,G
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:2)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0029422lidocaineD008012137-58-6osteochondrodysplasiasMESH:D010009therapeutic12238912
C0029422mexiletineD00880131828-71-4osteochondrodysplasiasMESH:D010009therapeutic12238912
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)